Market cap
$2,085 Mln
Revenue (TTM)
$1,226 Mln
P/E Ratio
75
P/B Ratio
2.6
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 3.27 | 2.36 | 4.44 | 4.82 | 2.93 |
| EBIT | 208.61 | 812.64 | 152.84 | 29.83 | -5.45 |
| Net Profit | 826.95 | 924.64 | 171.01 | 111.24 | 13.43 |
| EPS | 817.80 | 910.84 | 155.45 | 79.35 | -10.07 |
| Book Value | -- | -- | -9.94 | -6.16 | -2.03 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-22 | Dec-21 |
| EBIT-Margin
| 3.82 | 6.02 | 6.11 | 5.39 | 2.76 |
| Net Margin
| -1.98 | 0.16 | 2.33 | 3.41 | -5.75 |
| Return on equity
| -2.22 | 0.46 | 3.23 | 4.86 | -7.48 |
| Return on Capital
| -0.88 | 0.50 | -- | 2.20 | -3.01 |
| Return on Assets
| -0.81 | 0.39 | 1.03 | 1.85 | -2.64 |
| Debt to Equity (x)
| -- | -- | 0.50 | 1.16 | 1.27 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
--
|
2.20
|
-3.01
|
-1.83
|
4.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
3.23
Lower than Peers by 1.71
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
3.23
|
4.86
|
-7.48
|
-4.05
|
7.46
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
ROA
1.03
Lower than Peers by 1.43
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
1.03
|
1.85
|
-2.64
|
-1.62
|
3.63
|
|
Peer Median
|
2.45
|
--
|
--
|
--
|
--
|
EBIT Margin
6.11
Lower than Peers by 2.36
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
6.11
|
5.39
|
2.76
|
3.31
|
10.02
|
|
Peer Median
|
8.47
|
--
|
--
|
--
|
--
|
Net Margin
2.33
Lower than Peers by 2.34
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
2.33
|
3.41
|
-5.75
|
-3.59
|
5.60
|
|
Peer Median
|
4.68
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
4.44
Lower than Peers by 4.05
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
4.44
|
0.06
|
0.08
|
-0.10
|
0.06
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
EBIT Growth
152.84
Higher than Peers by 142.19
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
152.84
|
106.33
|
-9.82
|
-70.26
|
23.51
|
|
Peer Median
|
10.65
|
--
|
--
|
--
|
--
|
Net Profit Growth
171.01
Higher than Peers by 157.45
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
171.01
|
163.05
|
-72.49
|
-156.95
|
422.75
|
|
Peer Median
|
13.55
|
--
|
--
|
--
|
--
|
EPS Growth
155.45
Higher than Peers by 134.95
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
155.45
|
1.52
|
-0.73
|
-1.60
|
4.03
|
|
Peer Median
|
20.51
|
--
|
--
|
--
|
--
|
Book Value Growth
6.18
Lower than Peers by 0.83
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
6.18
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.01
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.50
Higher than Peers by 0.10
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
0.50
|
1.16
|
1.27
|
1.67
|
0.77
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.40
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
0.40
|
0.53
|
0.01
|
0.71
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.25
Lower than Peers by 1.58
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
1.25
|
1.21
|
3.99
|
1.87
|
3.69
|
|
Peer Median
|
2.83
|
--
|
--
|
--
|
--
|
Quick Ratio
0.65
Lower than Peers by 1.40
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
0.65
|
0.74
|
2.42
|
1.51
|
2.18
|
|
Peer Median
|
2.05
|
--
|
--
|
--
|
--
|
Interest Coverage
3.19
Lower than Peers by 1.77
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
3.19
|
3.72
|
1.49
|
0.49
|
3.04
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
21.78
Higher than Peers by 5.33
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
21.78
|
20.75
|
18.82
|
19.71
|
18.11
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.44
Lower than Peers by 0.06
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
0.44
|
0.55
|
0.47
|
0.46
|
0.65
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
--
|
70.47
|
67.58
|
72.77
|
63.79
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
--
|
355.17
|
349.33
|
348.09
|
342.42
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
--
|
128.05
|
128.08
|
117.86
|
118.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
--
|
297.59
|
288.84
|
303.00
|
287.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
75.00
Higher than Peers by 30.54
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
75.00
|
64.06
|
-42.37
|
-78.64
|
64.78
|
|
Peer Median
|
44.46
|
--
|
--
|
--
|
--
|
Price / Book Value
2.62
Lower than Peers by 1.22
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
2.62
|
2.98
|
3.41
|
3.18
|
4.62
|
|
Peer Median
|
3.84
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
19.40
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
19.40
|
15.79
|
19.20
|
19.48
|
18.66
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
2,085
Higher than Peers by 1,543
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
|---|---|---|---|---|---|
|
NuVasive (NUVA)
|
2,085
|
--
|
--
|
--
|
--
|
|
Peer Median
|
542
|
--
|
--
|
--
|
--
|